CD274 and non-small cell lung carcinoma: Several immune checkpoints have been used to treat numerous cancer types, such as melanoma, bladder, non-small cell lung cancer (NSCLC), and CRC, with the most popular being cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death ligand-1 (PD-L1) (8).